We are live on ! Find out more
SC

Schubert & Co Portfolio holdings

AUM $145M
1-Year Est. Return 6.77%
This Fund
S&P 500
This Quarter Est. Return
-0.33%
1 Year Est. Return
+6.77%
3 Year Est. Return
+47.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.4M
AUM Growth
–
Cap. Flow
+$97.4M
Cap. Flow %
98.98%
Top 10 Hldgs %
89.73%
Holding
1,399
New
1,396
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$67.4M
2
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$9.9M
3
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$3.28M
4
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$1.81M
5
AAPL icon
Apple
AAPL
+$1.26M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 71.38%
2 Miscellaneous 18.81%
3 Energy 1.9%
4 Healthcare 1.56%
5 Communication Services 1.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOG.A icon
1176
Moog Inc Class A
MOG.A
$11.3B
$0 ﹤0.01%
+5
New +$388
MRCY icon
1177
Mercury Systems
MRCY
$5.23B
$0 ﹤0.01%
+5
New +$253
MSGS icon
1178
Madison Square Garden
MSGS
$9.47B
$0 ﹤0.01%
+2
New +$363
MSM icon
1179
MSC Industrial Direct
MSM
$6.69B
$0 ﹤0.01%
+5
New +$418
MTDR icon
1180
Matador Resources
MTDR
$7.82B
$0 ﹤0.01%
+9
New +$368
MTSI icon
1181
MACOM Technology Solutions
MTSI
$18.3B
$0 ﹤0.01%
+5
New +$361
MTX icon
1182
Minerals Technologies
MTX
$2.11B
$0 ﹤0.01%
+6
New +$431
MWA icon
1183
Mueller Water Products
MWA
$3.56B
$0 ﹤0.01%
+26
New +$391
MXL icon
1184
MaxLinear
MXL
$6.09B
$0 ﹤0.01%
+2
New +$128
MYGN icon
1185
Myriad Genetics
MYGN
$371M
$0 ﹤0.01%
+5
New +$145
NBIX icon
1186
Neurocrine Biosciences
NBIX
$15.2B
$0 ﹤0.01%
+4
New +$368
NEOG icon
1187
Neogen
NEOG
$2.67B
$0 ﹤0.01%
+11
New +$471
NGVT icon
1188
Ingevity
NGVT
$2.33B
$0 ﹤0.01%
+5
New +$380
NKTR icon
1189
Nektar Therapeutics
NKTR
$2.28B
$0 ﹤0.01%
+1
New +$217
NMIH icon
1190
NMI Holdings
NMIH
$3.27B
$0 ﹤0.01%
+14
New +$311
NOVA
1191
DELISTED
Sunnova Energy
NOVA
$0 ﹤0.01%
+2
New +$72
NTB icon
1192
Bank of N.T. Butterfield & Son
NTB
$2.34B
$0 ﹤0.01%
+8
New +$304
NTCT icon
1193
NETSCOUT
NTCT
$2.79B
$0 ﹤0.01%
+14
New +$425
NTLA icon
1194
Intellia Therapeutics
NTLA
$1.59B
$0 ﹤0.01%
+1
New +$125
NTRA icon
1195
Natera
NTRA
$50.6B
$0 ﹤0.01%
+1
New +$104
NUS icon
1196
Nu Skin
NUS
$231M
$0 ﹤0.01%
+8
New +$356
NVAX icon
1197
Novavax
NVAX
$1.52B
$0 ﹤0.01%
+2
New +$344
NVCR icon
1198
NovoCure
NVCR
$1.88B
$0 ﹤0.01%
+1
New +$100
NWE icon
1199
NorthWestern Energy
NWE
$4.18B
$0 ﹤0.01%
+5
New +$284
NWBI icon
1200
Northwest Bancshares
NWBI
$2.28B
$0 ﹤0.01%
+5
New +$70
46 47
48
49 50

Similar funds

RCM
RMR Capital Management Tustin, California $145M AUM 12.93% 1-Year Est. Return
CCP
Cushing Capital Partners Delafield, Wisconsin $145M AUM 15.89% 1-Year Est. Return
MAM
McLaughlin Asset Management Danville, Illinois $145M AUM
GTWM
Global Trust Wealth Management West Palm Beach, Florida $145M AUM
HA
Hegarty Advisors Garden City, New York $145M AUM
BPW
Bingham Private Wealth San Francisco, California $145M AUM
WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
ACMG
Anchor Capital Management Group Aliso Viejo, California $145M AUM 25.76% 1-Year Est. Return

Schubert & Co's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Schubert & Co, which disclosed 1,399 positions worth $98.4M. Its ten largest holdings account for 90% of the portfolio.

Its largest position is Fiserv Inc: 652,164 shares worth $67.7M.

By sector, the portfolio is most concentrated in Technology at 71% of assets, followed by Miscellaneous and Energy.

  • Schubert & Co's largest Q4 2021 buy was Fiserv Inc: 652,164 shares worth $67.7M.
  • Schubert & Co's ten largest holdings make up 90% of its $98.4M portfolio in Q4 2021.
  • Schubert & Co disclosed 1,399 positions in Q4 2021, its first 13F filing on record.

Based on Schubert & Co's 13F filing for Q4 2021, filed 28 Jan 2022.